Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus

被引：3
|
作者：
Tuepker, J [1 ]
机构：
[1] Texas Tech Univ, Sch Pharm, Dallas, TX USA
来源：
CIRCULATION | 2003年 / 107卷 / 16期
关键词：
D O I：
10.1161/01.CIR.0000067693.46108.2D
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E109 / E109
页数：1
相关论文
共 50 条
  • [21] Rosiglitazone for type 2 diabetes mellitus
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 1999, 41 (1059): : 71 - +
  • [22] Rosiglitazone in the treatment of type 2 diabetes mellitus: A critical review
    Malinowski, JM
    Bolesta, S
    [J]. CLINICAL THERAPEUTICS, 2000, 22 (10) : 1151 - 1168
  • [23] Novel molecular markers of cardiovascular disease risk in type 2 diabetes mellitus
    Giglio, Rosaria Vincenza
    Stoian, Anca Pantea
    Haluzik, Martin
    Pafili, Kalliopi
    Patti, Angelo Maria
    Rizvi, Ali Abbas
    Ciaccio, Marcello
    Papanas, Nikolaos
    Rizzo, Manfredi
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2021, 1867 (08):
  • [24] Beneficial effects of rosiglitazone on novel cardiovascular risk factors in patients with Type 2 diabetes mellitus
    Kadoglou, N. P. E.
    Iliadis, F.
    Angelopoulou, N.
    Perrea, D.
    Liapis, C. D.
    Alevizos, M.
    [J]. DIABETIC MEDICINE, 2008, 25 (03) : 333 - 340
  • [25] Effect of Empagliflozin on the Metabolic Signature of Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease
    Kappel, Ben A.
    Lehrke, Michael
    Schutt, Katharina
    Artati, Anna
    Adamski, Jerzy
    Lebherz, Corinna
    Marx, Nikolaus
    [J]. CIRCULATION, 2017, 136 (10) : 969 - 972
  • [26] Rosiglitazone in the management of older patients with type 2 diabetes mellitus
    Kreider, M
    Heise, M
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2002, 56 (07) : 538 - 541
  • [27] Evaluation of Cardiovascular Disease Risk in Patients with Type 2 Diabetes Mellitus Using Clinical Laboratory Markers
    Ulambayar, Battamir
    Ghanem, Amr Sayed
    Chau, Nguyen Minh
    Faludi, Eszter Vargane
    More, Marianna
    Nagy, Attila Csaba
    [J]. JOURNAL OF CLINICAL MEDICINE, 2024, 13 (12)
  • [28] Biological variation of cardiovascular biochemical markers in patients with Type 2 Diabetes Mellitus
    Wang, Xia
    Zeng, Yuping
    He, He
    Zhang, Mei
    Li, Chuan
    Yang, Lidan
    Chen, Jie
    Huang, Hengjian
    [J]. CLINICA CHIMICA ACTA, 2022, 534 : 161 - 166
  • [29] Markers of cardiovascular complications in patients with type 2 diabetes mellitus and arterial hypertension
    Demikhova, N.
    Chernatska, O.
    Mazur, T.
    Bokova, S.
    Rudenko, T.
    Bumeister, L.
    Demikhov, O.
    [J]. BANGLADESH JOURNAL OF MEDICAL SCIENCE, 2018, 17 (02): : 319 - 322
  • [30] A Study of Nontraditional Biochemical Markers and Their Relation to the Level of Fasting Glycemia in Patients with Type 2 Diabetes Mellitus
    Nimmanapalli, Harini Devi
    Pasupuleti, Pullaiah
    Vakkakara, Suresh
    Rao, Srinivasa P. V. L. N.
    [J]. TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2018, 22 (04) : 225 - 230
12345